Misbah Tahir
Net worth: - $ as of 2026-06-29
Net worth: - $ as of 2026-06-29
Misbah Tahir is currently Chief Financial & Accounting Officer at Maze Therapeutics, Inc. since 2026.
Formerly, served as Chief Financial Officer at IGM Biosciences, Inc. from 2019 to 2025.
Previously, was Vice President & Head-Finance at Dermira, Inc. from 2014 to 2018.
Education includes undergraduate studies at the University of Pennsylvania and an MBA from Stephen M.
Ross School of Business.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases -.--% | 2026-03-30 | 0 ( -.--% ) | - $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Director of Finance/CFO | 2025-09-01 |
| Companies | Position | End |
|---|---|---|
| IGM BIOSCIENCES, INC. | Director of Finance/CFO | 2025-07-31 |
| DERMIRA, INC. | Corporate Officer/Principal | 2018-11-30 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stephen M. Ross School of Business
Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dermira, Inc.
Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
IGM Biosciences, Inc.
IGM Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops engineered IgM antibodies for the treatment of cancer patients | Health Technology |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions